User profiles for María del Mar Álvarez-Torres

María del Mar Álvarez-Torres

Columbia University Irving Medical Center
Verified email at cumc.columbia.edu
Cited by 147

[HTML][HTML] High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the …

OM Henriksen, M del Mar Álvarez-Torres… - Frontiers in …, 2022 - frontiersin.org
Objective Summarize evidence for use of advanced MRI techniques as monitoring biomarkers
in the clinic, and highlight the latest bench-to-bedside developments. Methods Experts in …

[HTML][HTML] High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the …

…, G Hangel, P Figueiredo, MDM Álvarez-Torres… - Frontiers in …, 2022 - frontiersin.org
Objective: To summarize evidence for use of advanced MRI techniques as monitoring biomarkers
in the clinic, and to highlight the latest bench-to-bedside developments. Methods: The …

[HTML][HTML] MGMT methylation may benefit overall survival in patients with moderately vascularized glioblastomas

…, D Lorente Estellés, MM Álvarez-Torres… - European …, 2021 - Springer
Objectives To assess the combined role of tumor vascularity, estimated from perfusion MRI,
and MGMT methylation status on overall survival (OS) in patients with glioblastoma. Methods …

[HTML][HTML] Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 …

MM Álvarez-Torres, E Fuster-García, J Juan-Albarracín… - BMC cancer, 2022 - Springer
Background The microvessels area (MVA), derived from microvascular proliferation, is a
biomarker useful for high-grade glioma classification. Nevertheless, its measurement is costly, …

[HTML][HTML] Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT

MM Álvarez-Torres, E Fuster-García, C Balaña, J Puig… - Cancers, 2021 - mdpi.com
Simple Summary Despite the complete treatment with surgery, chemotherapy and radiotherapy,
patients with glioblastoma have a devasting prognosis. Although the role of extending …

Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study

M del Mar ÁlvarezTorres… - Journal of Magnetic …, 2020 - Wiley Online Library
Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized
by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the …

[HTML][HTML] Unlocking Bevacizumab's Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients

MM Álvarez-Torres, C Balaña, E Fuster-García, J Puig… - Cancers, 2023 - mdpi.com
Simple Summary This study seeks to assess the efficacy of bevacizumab (BVZ) in the
context of glioblastoma treatment, with a particular focus on the identification of a predictive …

Vascular differences between IDH‐wildtype glioblastoma and astrocytoma IDH‐mutant grade 4 at imaging and transcriptomic levels

MM ÁlvarezTorres, A López‐Cerdán… - NMR in …, 2023 - Wiley Online Library
Global agreement in central nervous system (CNS) tumor classification is essential for
predicting patient prognosis and determining the correct course of treatment, as well as for …

Differential effect of vascularity between long‐and short‐term survivors with IDH1/2 wild‐type glioblastoma

MM ÁlvarezTorres, E Fuster‐García… - NMR in …, 2021 - Wiley Online Library
Introduction IDH1/2 wt glioblastoma (GB) represents the most lethal tumour of the central
nervous system. Tumour vascularity is associated with overall survival (OS), and the clinical …

ONCOhabitats glioma segmentation model

…, E Fuster-Garcia, M del Mar Álvarez-Torres… - … Sclerosis, Stroke and …, 2020 - Springer
ONCOhabitats is an open online service that provides a fully automatic analysis of tumor
vascular heterogeneity in gliomas based on multiparametric MRI. Having a model capable of …